BioMaxima S.A. (WSE:BMX)
Poland flag Poland · Delayed Price · Currency is PLN
13.85
-0.30 (-2.12%)
Jul 18, 2025, 5:00 PM CET

BioMaxima Revenue

BioMaxima had revenue of 15.28M PLN in the quarter ending March 31, 2025, with 32.51% growth. This brings the company's revenue in the last twelve months to 56.60M, up 19.81% year-over-year. In the year 2024, BioMaxima had annual revenue of 52.85M with 12.96% growth.

Revenue (ttm)
56.60M
Revenue Growth
+19.81%
P/S Ratio
1.03
Revenue / Employee
449.21K
Employees
126
Market Cap
58.07M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202452.85M6.07M12.96%
Dec 31, 202346.79M-97.08M-67.48%
Dec 31, 2022143.87M64.78M81.91%
Dec 31, 202179.09M17.81M29.06%
Dec 31, 202061.28M30.67M100.19%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
NEUCA12.82B
Voxel556.98M
Synektik Spólka Akcyjna592.94M
Celon Pharma215.11M
Ryvu Therapeutics97.57M
Selvita359.79M
Centrum Medyczne ENEL-MED762.83M
EMC Instytut Medyczny836.81M
Revenue Rankings